Ginkgo Bioworks Holdings, Inc. (DNA)
8.50
-1.11
(-11.55%)
USD |
NYSE |
Nov 16, 16:00
8.56
+0.06
(+0.71%)
After-Hours: 20:00
Ginkgo Bioworks Holdings EPS Diluted (Quarterly) : -0.6407 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.6407 |
| June 30, 2026 | -1.147 |
| March 31, 2026 | -1.386 |
| December 31, 2025 | -1.456 |
| September 30, 2025 | -1.452 |
| June 30, 2025 | -1.099 |
| March 31, 2025 | -1.677 |
| December 31, 2024 | -1.998 |
| September 30, 2024 | -1.080 |
| June 30, 2024 | -4.231 |
| March 31, 2024 | -3.311 |
| December 31, 2023 | -4.282 |
| September 30, 2023 | -6.210 |
| Date | Value |
|---|---|
| June 30, 2023 | -3.586 |
| March 31, 2023 | -4.290 |
| December 31, 2022 | -3.807 |
| September 30, 2022 | -16.44 |
| June 30, 2022 | -16.51 |
| March 31, 2022 | -14.69 |
| December 31, 2021 | -39.73 |
| September 30, 2021 | -2.741 |
| June 30, 2021 | -1.668 |
| March 31, 2021 | -2.281 |
| December 31, 2020 | -1.456 |
| September 30, 2020 | -0.7012 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Sotera Health Co. | 0.2019 |
| CareDx, Inc. | 0.3509 |
| Exagen, Inc. | -0.255 |
| Quest Diagnostics, Inc. | 2.768 |
| Labcorp Holdings, Inc. | 3.221 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -40.98M |
| Revenue (Quarterly) | 27.71M |
| Total Expenses (Quarterly) | 68.70M |
| Enterprise Value | 700.96M |
| Gross Profit Margin (Quarterly) | 50.04% |
| Profit Margin (Quarterly) | -147.9% |
| Earnings Yield | -54.47% |
| Normalized Earnings Yield | -53.68 |